Revised intimation of Conference Call on Q3FY26 and 9MFY26 financial results Change in Conference Call Timing
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkem Laboratories has revised the timing of its investor conference call to discuss its Q3FY26 and 9MFY26 financial results. The call, which was earlier scheduled for 4:00 PM IST on Friday, February 13, 2026, will now be held at 5:00 PM IST on the same date. The call will follow the company's Q3 and 9MFY26 results announcement, which is also slated for February 13, 2026. CEO Dr. Vikas Gupta and CFO Mr. Nitin Agrawal will represent the company, with Motilal Oswal Securities hosting the call. Dial-in details for participants in India, USA, UK, Singapore, and Hong Kong have been provided.
This is a routine administrative update with no material impact on the business or stock price. Investors and analysts participating in the call only need to note the new 5:00 PM IST start time instead of the earlier 4:00 PM slot.